PPARα and PPARγ ligands have also been shown to play a potential role in suppressing both hyperlipidemia and polyp formation in Apc gene-deficient mice, an animal model for human familial adenomatouspolyposis [28]. Here, PPARG is linked to hyperlipidemia.